PA
LXU icon

PharVision Advisers’s LSB Industries LXU Stock Holding History

PharVision Advisers’s Portfolio LXU Stock Details LXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,363
Closed -$411K – 414
2025
Q4 		$411K Sell
48,363
-24,393
-34% -$215K 0.21% 111
2025
Q3 		$573K Buy
+72,756
New +$590K 0.32% 14

Other funds holding LXU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RR
Robotti Robert $641M AUM 66.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

PharVision Advisers's LXU Position: Q1 2026 in Review

PharVision Advisers sold out of LSB Industries (LXU) in Q1 2026, closing a stake of 48,363 shares — an estimated $411K sold.

PharVision Advisers first reported a position in LXU in Q3 2025 and held it in 2 quarters. The position peaked at $573K in Q3 2025. 189 funds tracked by Wall St. Rank hold LXU as of Q1 2026.

  • PharVision Advisers reported no remaining LSB Industries position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 48,363 LSB Industries shares in Q1 2026, an estimated $411K.
  • PharVision Advisers first reported a position in LSB Industries in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's LSB Industries position peaked at $573K in Q3 2025.
  • 189 funds tracked by Wall St. Rank held LSB Industries as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.